Johnson & Johnson (JNJ) Change in Receivables (2009 - 2026)

Johnson & Johnson has disclosed Change in Receivables across 18 years of filings, most recently posting $1.4 billion for Q2 2026.

• In Q2 2026, Change in Receivables changed 0.37% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (down 5.31% YoY), while the FY2025 annual figure was $1.8 billion, up 338.67% from the prior year.
• Change in Receivables came in at $1.4 billion for Q2 2026 at Johnson & Johnson, up from $595.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.4 billion in Q2 2025 to a low of -$853.0 million in Q4 2024.
• Average Change in Receivables over 5 years is $291.1 million, with a median of $265.5 million recorded in 2023.
• The largest YoY upside for Change in Receivables was 416.67% in 2024 against a maximum downside of 275.77% in 2024.
• Over 5 years, Change in Receivables stood at $427.0 million in 2022, then sank by 153.16% to -$227.0 million in 2023, then plunged by 275.77% to -$853.0 million in 2024, then surged by 54.16% to -$391.0 million in 2025, then soared by 445.78% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $1.4 billion in Q2 2026, $595.0 million in Q1 2026, and -$391.0 million in Q4 2025.